Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00598702 · ClinicalTrials.gov registry record · Phase 3
Study of the Safety & Efficacy of Intravenous Acetaminophen in Pediatric Inpatients
A Phase 3 study, sponsored by Mallinckrodt.
- Completed
- Registry status
- Phase 3
- Development phase
- 100
- Enrollment target
NCT00598702 is a Phase 3 study that has completed, run by Mallinckrodt. The registered enrollment target is 100 participants.
The verdict
NCT00598702, a Phase 3 study, has completed, sponsored by Mallinckrodt.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 100 participants
- Enrollment target
Study Summary
Intravenous acetaminophen (IVAPAP) is safe in repeated dose, multi-day clinical use when administered at a daily dose of 40 to 75 mg/kg body weight
Interventions
- DRUG IV Acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2008-01 |
| Est. Completion | 2009-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00598702
The ClinicalTrials.gov registry entry for NCT00598702 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mallinckrodt, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IV Acetaminophen is the first listed.
NCT00598702 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00598702 about?
NCT00598702 is a clinical study titled "Study of the Safety & Efficacy of Intravenous Acetaminophen in Pediatric Inpatients". Intravenous acetaminophen (IVAPAP) is safe in repeated dose, multi-day clinical use when administered at a daily dose of 40 to 75 mg/kg body weight
What is the current status of trial NCT00598702?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 100 participants. The study started on 2008-01. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00598702?
The interventions under investigation include: IV Acetaminophen (DRUG).
Who is sponsoring clinical trial NCT00598702?
This trial is sponsored by Mallinckrodt, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.